Zobrazeno 71 - 80
of 96
pro vyhledávání: '"Andrew J. Gifford"'
Autor:
David S. Ziegler, Erica Jacobsen, Richard J. Cohn, Annie M.E. Bye, Andrew J. Gifford, Alexandra M. Johnson
Publikováno v:
Neuro-Oncology. 20:i42-i42
Paediatric extraventricular neurocytoma (EVN) is a rare central nervous system (CNS) tumour accounting for 0.1% of CNS tumours (Liu et al 2013). Limited data exists regarding presentation and outcome of paediatric EVN. A retrospective review of patie
Publikováno v:
Pathology. 50:S144
Autor:
Loretta Lau, Chelsea Mayoh, Jinhan Xie, David Thomas, Alvin Kamili, Marie Wong, Mark J. Cowley, Paul G Ekert, Emily Mould, Michelle Haber, Andrew J. Gifford, Vanessa Tyrrell, Jamie I. Fletcher, Tim Failes, Greg M. Arndt, Paulette Barahona, Richard B. Lock, Toby Trahair, Dong Anh Khuong-Quang, Maria Tsoli, Meera Wharby, Glenn M. Marshall, Kathryn Tucker, David S. Ziegler, Tracey A. O'Brien, Scott Mead, Mark Pinese, Amit Kumar
Publikováno v:
Pathology. 50:S31
Autor:
Jinhan Xie, Karen L. MacKenzie, Andrew J. Gifford, Toby Trahair, Ashleigh M. Fordham, Emily Mould
Publikováno v:
Clinical Cancer Research. 24:A19-A19
Inflammatory myofibroblastic tumors (IMTs) are sarcomas of soft tissue that most commonly arise in children, adolescents, and young adults. If not cured by surgery, IMT has a high propensity for local recurrence as multifocal nodules, and may rapidly
Publikováno v:
Annals of the American Thoracic Society. 13:297-298
Autor:
Norris, Larry H. Matherly, Teah L. Witt, Jeffrey W. Taub, Andrew J. Gifford, Whetstine, Michelle Haber
Publikováno v:
Leukemia. 16:2379-2387
Resistance to the antifolate methotrexate (MTX) can cause treatment failure in childhood acute lymphoblastic leukemia (ALL). This may result from defective MTX accumulation due to alterations in the human reduced folate carrier (hRFC) gene. We have i
Autor:
Emily Mould, Murray D. Norris, Amit Kumar, Paul G Ekert, Loretta Lau, Andrew Fellowes, Richard B. Lock, Michelle Haber, Toby Trahair, Andrew J. Gifford, Jennifer Byrne, Tim Failes, Jinhan Xie, Maria Tsoli, Vanessa Tyrrell, Carol Wadham, Geoffrey McCowage, David S. Ziegler, Jamie I. Fletcher, Glenn M. Marshall
Publikováno v:
Journal of Clinical Oncology. 35:10539-10539
10539 Background: Genomic analyses can identify actionable mutations in a subset of childhood cancers. However it has been challenging to translate actionable mutations into substantial benefits for adult cancers despite high mutation frequency. Meth
Autor:
Barbara B. Sterkel, Mark Sywak, Goswin Y. Meyer-Rochow, Frank E. Johnson, Andrew J. Gifford, Theresa Schwartz, Jaswinder S. Samara
Publikováno v:
The American Journal of Surgery. 197:e61-e63
A patient with a pancreatic mass noted on a computed tomography scan was suspected of having a nonfunctioning pancreatic neuroendocrine neoplasm. The eventual diagnosis of intrapancreatic accessory spleen was made by noninvasive means, thus avoiding
Autor:
Maria Kavallaris, Michelle Haber, Janice Madafiglio, Bernard W. Stewart, Murray D. Norris, Larry H. Matherly, Andrew J. Gifford
Publikováno v:
International Journal of Cancer. 78:176-181
We have previously described a series of methotrexate (MTX)-selected CCRF-CEM sublines (CEM/MTX R1–3) displaying increased resistance to drugs associated with the multidrug resistance phenotype and have provided evidence that MDR1 P-glycoprotein co
Autor:
Federica Saletta, Selina K. Sutton, Joanna Tsang, Jessica Koach, Bing Liu, André Oberthuer, Sarah Syed, Natalia Issaeva, Michelle Haber, Heyam Kalla, Dora Ling, Bernard Atmadibrata, Nicolas Sokolowski, Andrei Purmal, Glenn M. Marshall, Jennifer A. Byrne, Laura D. Gamble, Michelle Ruhle, Andrei V. Gudkov, Daniel R. Carter, Belamy B. Cheung, Matthias Fischer, Patrick Y. Kim, Murray D. Norris, Hannah Webber, Katerina Gurova, Andrew J. Gifford, David S. Ziegler, Jayne Murray, Tao Liu, Ashleigh Clark, Yuting Sun, Asel Biktasova
Publikováno v:
Molecular Cancer Research. 13:PR09-PR09
Neuroblastoma is a childhood cancer of the sympathetic nervous system. Approximately 20% of patients present with an aggressive metastatic disease characterized by amplification of the MYCN locus. However, an additional 30% of patients suffer from an